Our Experience
The Key Enabler for Drug and Biomarker Discovery & Development
5/5

Vivia Biotech has pioneered worldwide the development of “Native Environment” assays in patient whole samples across several indications and multiple mechanisms of action, capable of delivering truly translational pharmacological data that correlates with patient treatment outcome.

With these assets, Vivia Biotech has successfully engaged in partnering with a number of pharmaceutical and biotechnology companies worldwide to provide unique precision medicine capabilities for patient-centric drug development and biomarker discovery.
> 0

year experience working with complex Native Environment assays

> 0

collaborations in preclinical, translational and Companion Diagnosis in clinical trials

> 0

drugs profiled

> 0

multinational clients: top Pharma and large Biotech’s